<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="15889">Sterol</z:chebi> regulatory element-binding protein (SREBP)-1 transcription factors play a central role in energy homeostasis by promoting glycolysis, lipogenesis, and adipogenesis </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:chebi fb="0" ids="15889">sterol</z:chebi> regulatory element-binding protein gene (SREBF)-1 is a good candidate gene for <z:hpo ids='HP_0001513'>obesity</z:hpo> and <z:hpo ids='HP_0001513'>obesity</z:hpo>-related metabolic traits such as type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>The SREBF-1 molecular screening of 40 unrelated <z:mp ids='MP_0001261'>obese</z:mp> patients by PCR/single-strand conformation polymorphism revealed 19 single nucleotide polymorphisms (SNPs) </plain></SENT>
<SENT sid="3" pm="."><plain>Six SNPs were genotyped for an association study in large French <z:mp ids='MP_0001261'>obese</z:mp> and nonobese cohorts </plain></SENT>
<SENT sid="4" pm="."><plain>Case-control studies using two independent nonobese cohorts indicated that SNP17 (54G/C, exon 18c) is associated with morbid <z:hpo ids='HP_0001513'>obesity</z:hpo> (odds ratio 1.5, P = 0.006 and P = 0.02, respectively) </plain></SENT>
<SENT sid="5" pm="."><plain>SNP3 (-150G/A, exon 1a), SNP5 (-36delG, exon 1a), and SNP17 are found in high linkage disequilibrium (D' &gt; 0.8) </plain></SENT>
<SENT sid="6" pm="."><plain>The haplotype including <z:mp ids='MP_0002169'>wild-type</z:mp> alleles of these SNPs (C/G/G/T/C/G, HAP2) is identified as a risk factor for morbid <z:hpo ids='HP_0001513'>obesity</z:hpo> (P = 0.003) </plain></SENT>
<SENT sid="7" pm="."><plain>In the <z:mp ids='MP_0001261'>obese</z:mp> group, SNP3, SNP5, and SNP17 are associated with male-specific <z:hpo ids='HP_0002155'>hypertriglyceridemia</z:hpo> (P = 0.07, P = 0.01, and P = 0.05, respectively) </plain></SENT>
<SENT sid="8" pm="."><plain>SNP17 is also associated with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (P = 0.03) and increased prevalence of <z:hpo ids='HP_0000112'>nephropathy</z:hpo> (P = 0.028) in a diabetic cohort </plain></SENT>
<SENT sid="9" pm="."><plain>Our results indicate a role of the SREBF-1 gene in genetic predisposition of <z:e sem="disease" ids="C0025517" disease_type="Disease or Syndrome" abbrv="">metabolic diseases</z:e> such as <z:hpo ids='HP_0001513'>obesity</z:hpo>, type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, and <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e> </plain></SENT>
</text></document>